COVID-19 Vaccine to Cost Less Than Rs 250: Serum Institute

0

Pune-based Serum Institute of India (SII) announced on Friday, 7 August, that it would introduce candidate vaccines from AstraZeneca and Novavax for COVID-19 at less than Rs 250 per dose in India. According to IANS, the institute said it would offer up to 100 million doses at a price capped at $3 for 92 low and middle-income countries (LMIC), including India.

WHEN WILL THE VACCINES BE AVAILABLE?

SII has said the vaccines will be made available by first half of 2021, after receiving approvals and qualifications from the World Health Organisation (WHO), reported IANS. Further, SII said that if approved, Novavax’s vaccine will be available to 92 countries, while AstraZeneca’s will be available to 57.